Coronavirus disease 2019 (COVID-19) has spread worldwide. To date, no specific drug for COVID-19 has been developed. Thus, this randomized, open-label, controlled clinical trial (ChiCTR2000029853) was performed in China. A total of 20 mild and common COVID-19 patients were enrolled and randomly assigned to receive azvudine and symptomatic treatment (FNC group), or standard antiviral and symptomatic treatment (control group). The mean times of the first nucleic acid negative conversion (NANC) of ten patients in the FNC group and ten patients in the control group are 2.60 (SD 0.97; range 1-4) d and 5.60 (SD 3.06; range 2-13) d, respectively (p = 0.008). The mean times of the first NANC of four newly diagnosed subjects in the FNC group and ten subjects in the control group are 2.50 (SD 1.00; range 2-4) d and 9.80 (SD 4.73; range 3-19) d, respectively (starting from the initial treatment) (p = 0.01). No adverse events occur in the FNC group, while three adverse events occur in the control group (p = 0.06). The preliminary results show that FNC treatment in the mild and common COVID-19 may shorten the NANC time versus standard antiviral treatment. Therefore, clinical trials of FNC treating COVID-19 with larger sample size are warranted.

We used 1954–1983 surface temperature from 42 Chinese urban (average population 1.7*106) and rural (average population 1.5*105) station pairs to study the urban heat island effects. Despite the fact that the rural stations are not true rural stations, the magnitude of the heat islands was calculated to average 0.23 °C over the thirty‐year period with a minimum value during the 1964–1973 decade and maximum during the most recent decade. The urban heat islands were found to have seasonal dependence which varied considerably across the country. The urban heat islands also had a strong regional dependence with the Northern Plains dominating the magnitude of the heat islands. The changes in heat island intensity over three decades studied suggest a general increase in heat island intensity of about 0.1°C, but this has not been constant in time. These results suggest that caution must be exercised when attributing causes to observed trends when stations are located in the vicinity of metropolitan areas.

No abstract

Compounds released by mungbean roots potentially represent an enormous source of nitrogen (N) and carbon (C) in mungbean-oat intercropping systems. In this study, an in situ experiment was conducted using a 15N - 13C double stem-feeding method to measure N and C derived from the rhizodeposition (NdfR and CdfR) of mungbean and their transfer to oats in an intercropping system. Mungbean plants were sole cropped (S) or intercropped (I) with oat. The plants were labeled 5 weeks after planting and were harvested at the beginning of pod setting (Ip and Sp) and at maturity (Im and Sm). More than 60% and 50% of the applied 15N and 13C, respectively, were recovered in each treatment, with 15N and 13C being quite uniformly distributed in the different plant parts. NdfR represented 9.8% (Sp), 9.2% (Ip), 20.1% (Sm), and 21.2% (Im) of total mungbean plant N, whereas CdfR represented 13.3% (Sp), 42.0% (Ip), 15.4% (Sm), and 22.6% (Im) of total mungbean plant C. When considering the part of rhizodeposition transferred to associated oat, intercropping mungbean released more NdfR and CdfR than mungbean alone. About 53.4–83.2% of below-ground plant N (BGP-N) and 58.4–85.9% of BGP-C originated from NdfR and CdfR, respectively. The N in oats derived from mungbean increased from 7.6% at the pod setting stage to 9.7% at maturity, whereas the C in oats increased from 16.2% to 22.0%, respectively. Only a small percentage of rhizodeposition from mungbean was transferred to oats in the intercropping systems, with a large percentage remaining in the soil. This result indicates that mungbean rhizodeposition might contribute to higher N and C availability in the soil for subsequent crops.